Reduced [3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder

Journal of Neurochemistry

Volumn 68, Issue 1, 1997, Pages 297-304

  Rahman, Shafiqur ^a   Li, Peter P ^a,b,c   Young, L Trevor ^d   Kofman, Ora ^e   Kish, Stephen J ^a,b,c   Warsh, Jerry J ^a,b,c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Bipolar affective disorder; Cyclic AMP dependent protein kinase; Lithium; Postmortem brain

Indexed keywords

ADENYLATE KINASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; LITHIUM; TRITIUM;

ARTICLE; AUTOPSY; CEREBELLUM; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; MALE; MANIC DEPRESSIVE PSYCHOSIS; OCCIPITAL CORTEX; PARIETAL LOBE; PRIORITY JOURNAL; TEMPORAL CORTEX; THALAMUS; ADULT; AGED; ANIMAL; BIPOLAR DISORDER; BRAIN; CADAVER; METABOLISM; MIDDLE AGED; RAT; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BIPOLAR DISORDER; BRAIN; CADAVER; CYCLIC AMP; FEMALE; HUMANS; LITHIUM; MALE; MIDDLE AGED; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TRITIUM;

EID: 0030614785     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68010297.x     Document Type: Article

References (40)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd edit., revised. American Psychiatric Press, Washington, D.C.
2. Avissar S. and Schreiber G. (1992) The involvement of guanine nucleotide binding proteins in the pathogenesis and treatment of affective disorders. Biol. Psychiatry 31, 435-459.
3. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein - dye binding. Anal. Biochem. 72, 248-252.
4. β regulatory subunit to lose its ability to revert transformed fibroblasts. Proc. Natl. Acad. Sci. USA 92, 10634-10638.
5. Cho-Chung Y. S. and Clair T. (1993) The regulatory subunit of cAMP-dependent protein kinase as a target for chemotherapy of cancer and other cellular dysfunctional-related disease. Pharmacol. Ther. 60, 265-288.
6. Doskeland S. O. and Ogreid D. (1981) Binding proteins for cyclic AMP in mammalian tissues. Int. J. Biochem. 13, 1-19.
7. Doskeland S. O., Maronde E., and Gjertsen B. T. (1993) The genetic subtypes of cAMP-dependent protein kinase - functionally different or redundant. Biochim. Biophys. Acta 1178, 249-258.
8. Francis S. H. and Corbin J. D. (1994) Structure and function of cyclic nucleotide-dependent protein kinases. Annu. Rev. Physiol. 56, 237-272.
9. Garrel G., Delahaye R., Hemmings B. A., and Counis R. (1995) Modulation of regulatory and catalytic subunit levels of cAMP-dependent protein kinase A in anterior pituitary cells in response to direct activation of protein kinases A and C or after GnRH stimulation. Neuroendocrinology 62, 514-522.
10. Greenberg S. M., Castellucci V. F., Bayley H., and Schwartz J. H. (1987) A molecular mechanism for long-term sensitization in Aplysia. Nature 329, 62-65.
11. Harrison P. J., Heath P. R., Eastwood S. L., Burnet P. W. J., McDonald B., and Pearson R. C. A. (1995) The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci. Lett. 200, 151-154.
12. Hudson C. J., Young L. T., Li P. P., and Warsh J. J. (1993) CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse 13, 278-293
13. Jones C. L., Hodge V. F., Schoengold D. M., Biesiada H., and Starks T. H. (1987) An Interlaboratory Study of Inductively Coupled Plasma Atomic Emission Spectroscopy Method 6010 and Digestion Method 3050. Publication no. EPA-600/4-87-032, U.S. Environmental Protection Agency, Las Vegas, Nevada.
14. Jones D. J. and Stavinoha W. B. (1979) Microwave inactivation as a tool for studying the neuropharmacology of cyclic nucleotides, in Neuropharmacology of Cyclic Nucleotides (Palmer G. C., ed), pp. 253-281. Urban and Schwarzenberg, Munich.
15. Jope R. S., Song L., Li P. P., Young L. T., Kish S. J., Pacheco M. A., and Warsh J. J. (1996) The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain. J. Neurochem. 66, 2402-2409.
16. 1H-magnetic resonance spectroscopy in bipolar disorder. Psychiatry Res. 45, 53-63.
17. Licameli V., Mattiace L. A., Erlichman J., Davies P., Dickson D., and Shafit-Zagardo B. (1992) Regional localization of the regulatory subunit (RIIβ) of the type II cAMP-dependent protein kinase in human brain. Brain Res. 578, 61-68.
18. Liu A. Y.-C., Chan T., and Chen K. Y. (1981) Induction of the regulatory subunit of type I adenosine cyclic 3′,5′-monophosphate-dependent protein kinase in differentiated N-18 mouse neuroblastoma cells. Cancer Res. 41, 4579-4587.
19. Manji H. K. (1992) G proteins: implications for psychiatry. Am. J. Psychiatry 149, 746-760.
20. q/11 immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorder. Biol. Psychiatry (in press).
21. McPherson G. A. (1985) Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC. J. Pharmacol. Methods 14, 213-218.
22. oα immunoreactivities in left temporal cortices from patients with schizophrenia. Brain Res. 615, 41-49.
23. Ogreid D. and Doskeland S. O. (1981) The kinetics of association of cyclic AMP to the two types of binding sites associated with protein kinase II from bovine myocardium. FEBS Lett. 129, 287-292.
24. Ogreid D., Doskeland S. O., and Miller J. P. (1983) Evidence that cyclic nucleotides activating rabbit muscle protein kinase I interact with both types of cAMP binding sites associated with the enzyme. J. Biol. Chem. 258, 1041-1049.
25. Ogreid D., Ekanger R., Suva R. H., Miller J. P., and Doskeland S. O. (1989) Comparison of the two classes of binding sites (A and B) of type I and type II cyclic-AMP dependent protein kinases by using cyclic nucleotide analogues. Eur. J. Biochem. 181, 19-31.
26. Prashad N. and Rosenberg R. N. (1978) Induction of cyclic AMP-binding proteins by dibutyryl cyclic AMP in mouse neuroblastoma cells. Biochim. Biophys. Acta 539, 459-469.
27. Perez J., Tinelli D., Brunello N., and Racagni G. (1989) cAMP dependent phosphorylation of soluble and microtubule fraction after prolonged DMI treatment in rat cerebral cortex. Eur. J. Pharmacol. 172, 305-316.
28. Perez J., Tinelli D., Bianchi E., Brunello N., and Racagni G. (1991) cAMP binding proteins in the rat cerebral cortex after administration of selective 5-HT and NE reuptake blockers with antidepressant activity. Neuropsychopharmacology 4, 57-64.
29. Perez J., Zanardi R., Mori S., Gasperini M., Smeraldi E., and Racagni G. (1995) Abnormalities of cAMP-dependent endogenous phosphorylation in platelets from patients with bipolar disorder. Am. J. Psychiatry 152, 1204-1206.
30. Sachs G. S., Renshaw P. F., Lafer B., Stoll A. L., Guimaraes A. R., Rosenbaum J. F., and Gonzalez R. G. (1995) Variability of brain lithium levels during maintenance treatment: a magnetic resonance spectroscopy study. Biol. Psychiatry 38, 422-428.
31. Sampson M., Ruddel M., and Elin R. J. (1994) Lithium determinations evaluated in eight analyzers. Clin. Chem. 40, 869-872.
32. Schreiber G., Avissar S., Danon A., and Belmaker R. H. (1991) Hyperfunctional G proteins in mononuclear leukocytes of patients with mania. Biol. Psychiatry 29, 273-280.
33. Spaulding S. W. (1993) The ways in which hormones change cyclic adenosine 3′,5′-monophosphate-dependent protein kinase subunits, and how such changes affect cell behavior. Endocr. Rev. 14, 632-650.
34. Stein J. C., Farooq M., Norton W. T., and Rubin C. S. (1987) Differential expression of isoforms of the regulatory subunit of type II cAMP-dependent protein kinase in rat neurons, astrocytes and oligodendrocytes. J. Biol. Chem. 262, 3002-3006.
35. Walaas S. I. and Greengard P. (1991) Protein phosphorylation and neuronal function. Pharmacol. Rev. 43, 299-349.
36. Walter U., Kanof P., Schulman H., and Greengard P. (1978) Adenosine 3′,5′-monophosphate receptor proteins in mammalian brain. J. Biol. Chem. 253, 6275-6280.
37. Warsh J. J. and Li P. P. (1996) Second messenger systems and mood disorders. Curr. Opin. Psychiatry 9, 23-29.
38. s α subunit levels are elevated in bipolar affective disorder. Brain Res. 553, 323-326.
39. sα protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J. Neurochem. 61, 890-898.
40. Young L. T., Li P. P., Kamble A., Siu K. P., and Warsh J. J. (1994) Mononuclear leukocyte levels of G proteins in depressed patients with bipolar or major depressive disorder. Am. J. Psychiatry 151, 594-596.